SB 394 adds bacterial vaginosis to Maryland's list of conditions eligible for expedited partner therapy (EPT). This allows certain healthcare providers - like physicians, advanced practice nurses, and pharmaciststo prescribe antibiotics to a sexual partner of a diagnosed patient without requiring a personal examination of the partner. The law aims to prevent reinfection in the diagnosed patient and stop disease spread, expanding existing EPT rules that previously covered only chlamydia, gonorrhea, and trichomoniasis. It applies to public and private health care settings in Maryland starting October 1, 2026.
SB 412 establishes Maryland’s Community Forensic Aftercare Program within the Maryland Department of Health. The program monitors two groups: individuals committed to the health department due to being "not criminally responsible" (often called "not guilty by reason of insanity" cases), and people with mental illness or intellectual disability requiring community monitoring under specific legal circumstances. Key mechanisms include creating a community monitoring board to decide on conditional release and out-of-state travel, and requiring licensed social workers ("Program Monitors") to track compliance with court orders and make health recommendations. The bill amends Maryland’s Criminal Procedure and Health codes to implement this program, focusing on safety and structured oversight for these individuals.
SB 326 expands the authority of physician assistants (PAs) in Maryland by allowing them to perform specific healthcare actions currently restricted to physicians. The bill directly affects PAs, patients requiring guardianship, inmates needing infirmary care, and mental health facilities by adding PAs to certification requirements for treatment incapacity (Section 5-606), guardianship petitions (Section 13-705), and inmate infirmary admissions (Section 9-601.1). It also requires the Maryland Department of Health to cover PA examinations for emergency evaluations and adds PAs to the Statewide Advisory Commission on Immunization. These changes aim to align PA practice with other licensed healthcare professionals in defined clinical scenarios.
SB 439 prohibits Maryland fire and rescue public safety employers from taking negative employment actions (like firing or denying promotions) against employees who use medical cannabis, provided the employee has a valid medical cannabis certification under state law. It amends existing Maryland law to explicitly add this protection for public safety workers, aligning with current medical cannabis certification requirements. The bill does not change how medical cannabis is certified but ensures these employees cannot face discrimination solely for using cannabis legally under the state program. This applies to all fire and rescue employees who meet the state's medical cannabis eligibility criteria.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
SB 449 extends workers' compensation benefits to Carroll County correctional deputies who develop heart disease or hypertension. It creates a legal presumption that these conditions are work-related (and thus compensable) if they result in partial disability or death, provided the condition is more severe than any pre-existing condition and the deputy had a medical exam before employment. The bill amends Maryland law to explicitly include "Carroll County Correctional Deputy" in the definition of "public safety employee" for these benefits. This change applies specifically to Carroll County deputies and requires meeting the severity and medical exam conditions to qualify.
HB 672 amends the Maryland Pediatric Cancer Fund to specify that only nonprofit hospitals, educational institutions, and other nonprofit organizations may receive grants for pediatric cancer research, removing previous eligibility for physicians, laboratories, and individuals. The bill requires grant funds to be used exclusively for direct research costs, prohibiting use for administrative overhead or community-based services. It also mandates annual reporting to the General Assembly on fund administration, promotional efforts, and detailed fund usage.
SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
This bill expands Maryland's child abuse reporting requirements by explicitly including female genital mutilation in the legal definition of abuse, which directly affects healthcare providers, educators, and other mandated reporters. It mandates that these professionals report suspected cases of female genital mutilation to authorities and increases penalties for violations while allowing individuals subjected to the procedure to file civil lawsuits for relief. The legislation also requires the Maryland Department of Health to create and distribute educational materials about female genital mutilation in partnership with various public and private organizations. Additionally, the bill authorizes health licensing boards to revoke licenses of individuals who commit violations related to female genital mutilation under specific circumstances.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.